Wednesday, March 05, 2025 | 03:30 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Patanjali refutes IMA's claims; releases research papers on Coronil

To support its argument, Patanjali has released a bunch of scientific papers on its research for a Covid-19 medicine that was published in popular peer-reviewed journals

Coronil launch
Premium

Yoga guru Ramdev flanked by Union ministers Harsh Vardhan (left) and Nitin Gadkari at last week’s launch of Coronil PTI

Arnab Dutta New Delhi
A day after Indian Medical Association's (IMA) scathing attack against Patanjali's Covid-19 medicine, the Ayurveda major on Wednesday hit back with scientific research papers and alleged that the body fabricating facts.

“Coronil is an evidence-based medicine with the integration of scientifically validated research evidence under pre-medical and clinical expertise," Patanjali Ayurved said, in response to the IMA's letter.

Its ingredients have been in the public domain and Coronil has been “thoroughly reviewed and scrutinised by the competent licensing authority. Therefore, Coronil is in no way a secret medicine, as portrayed by IMA officials. Stating such vague and erroneous statements is

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in